Skip to main content

Advertisement

Log in

A patients’ and caregivers’ perspective on hepatic encephalopathy

  • Original Paper
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Awareness of previous hepatic encephalopathy (HE) and compliance with treatment can probably reduce HE recurrence. The aim of this study was to assess the degree of awareness of previous HE and its treatment in a group of cirrhotic patients and their caregivers. Thirty-five cirrhotic patients with a history of HE and their caregivers (n = 31) were enrolled. Patients underwent evaluation of HE (clinical, psychometry and electroencephalography), quality of life (SF36 questionnaire), and awareness of HE/treatment on an ad hoc questionnaire (QAE). Caregivers underwent the QAE plus the Caregiver Burden Inventory. On the day of study, 7 patients were unimpaired, 8 had minimal and 20 low-grade overt HE. Of the patients, 37 % were aware of previous HE, 6 % of being on treatment and 6 % understood treatment effects. Of the caregivers, 48 % were aware of previous HE, 6 % of their relative being on treatment and 6 % understood treatment effects. Significant correlations were observed between neuropsychiatric status/linear HE indices and both the patients’ quality of life and the caregivers’ burden. In conclusion, HE awareness was poor in both patients and caregivers, most likely in relation to insufficient/inadequate provision of information.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Amodio P, Marchetti P, Del Piccolo F et al (1999) Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 110:1334–1344

    Article  PubMed  CAS  Google Scholar 

  • Amodio P, Campagna F, Olianas S et al (2008) Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 49:346–353

    Article  PubMed  Google Scholar 

  • Bajaj JS, Schubert CM, Heuman DM et al (2010) Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 138:2332–2340

    Article  PubMed  Google Scholar 

  • Conn HO, Leevy CM, Vlahcevic ZR et al (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 72:573–583

    PubMed  CAS  Google Scholar 

  • Ferenci P, Lockwood A, Mullen K et al (2002) Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721

    Article  PubMed  Google Scholar 

  • Groeneweg M, Quero JC, De Bruijn I et al (1998) Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28:45–49

    Article  PubMed  CAS  Google Scholar 

  • Montagnese S, Biancardi A, Schiff S et al (2011) Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology 53:558–566

    Article  PubMed  CAS  Google Scholar 

  • Novak M, Guest C (1989) Application of a multidimensional caregiver burden inventory. Gerontologist 29:798–803

    Article  PubMed  CAS  Google Scholar 

  • Prasad S, Dhiman RK, Duseja A et al (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45:549–559

    Article  PubMed  Google Scholar 

  • Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649

    Article  PubMed  CAS  Google Scholar 

  • Riggio O, Efrati C, Catalano C et al (2005) High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology 42:1158–1165

    Article  PubMed  Google Scholar 

  • Riggio O, Ridola L, Pasquale C et al (2011) Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 9:181–183

    Article  PubMed  Google Scholar 

  • Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  • Weissenborn K, Ennen JC, Schomerus H et al (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773

    Article  PubMed  CAS  Google Scholar 

Download references

No financial support

No conflicts of interest

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Montagnese.

Appendices

Appendix 1A

Questionnaire on the Awareness of Encephalopathy (QAE), patients’ version; to be filled in by the health professional (doctor, nurse etc.).

figure a

Appendix 1B

Questionnaire on the Awareness of Encephalopathy (QAE), caregivers’ version; to be filled in by the health professional (doctor, nurse etc.).

figure b

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montagnese, S., Amato, E., Schiff, S. et al. A patients’ and caregivers’ perspective on hepatic encephalopathy. Metab Brain Dis 27, 567–572 (2012). https://doi.org/10.1007/s11011-012-9325-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-012-9325-7

Keywords

Navigation